Location: New York, NY
CIK: 0001839435 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $651M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | 3,130,000 | $119M | 18.3% | $47.59 | -7.7% | COM | 03753U106 |
| ROIV | ROIVANT SCIENCES LTD | 4,367,000 | $51.01M | 7.8% | $8.56 | +32.1% | SHS | G76279101 |
| — | CYMABAY THERAPEUTICS INC | 3,073,750 | $45.83M | 7.0% | $7.72 | — | COM | 23257D103 |
| — | VERONA PHARMA PLC | 2,369,000 | $38.61M | 5.9% | $17.59 | — | SPONSORED ADS | 925050106 |
| IMVT | IMMUNOVANT INC | 1,000,000 | $38.39M | 5.9% | — | — | Put | 45258J102 |
| RCUS | ARCUS BIOSCIENCES INC | 1,968,000 | $35.33M | 5.4% | $33.27 | -39.6% | COM | 03969F109 |
| INSM | INSMED INC | 1,284,000 | $32.42M | 5.0% | $21.76 | +5.1% | COM PAR $.01 | 457669307 |
| — | MIRATI THERAPEUTICS INC | 655,051 | $28.53M | 4.4% | $52.54 | — | COM | 60468T105 |
| APLS | APELLIS PHARMACEUTICALS INC | 675,000 | $25.68M | 3.9% | $47.59 | -7.7% | Put | 03753U106 |
| BBIO | BRIDGEBIO PHARMA INC | 971,639 | $25.62M | 3.9% | $30.51 | -7.0% | COM | 10806X102 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 759,898 | $20.91M | 3.2% | $25.60 | +22.5% | COM NEW | 15117B202 |
| — | 89BIO INC | 1,219,157 | $18.82M | 2.9% | $16.51 | — | COM | 282559103 |
| — | RENEO PHARMACEUTICALS INC | 2,279,870 | $17.36M | 2.7% | $6.46 | — | COM | 75974E103 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,067,143 | $16.37M | 2.5% | $24.88 | -23.3% | COM | 92790C104 |
| APLS | APELLIS PHARMACEUTICALS INC | 400,000 | $15.22M | 2.3% | $47.59 | -7.7% | Call | 03753U106 |
| ANTX | AN2 THERAPEUTICS INC | 867,575 | $13.95M | 2.1% | $7.89 | +43.6% | COM | 037326105 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 695,000 | $12.73M | 2.0% | $21.15 | 0.0% | COM | 03237H101 |
| TSHA | TAYSHA GENE THERAPIES INC | 2,777,778 | $8.778M | 1.3% | $1.87 | 0.0% | COM SHS | 877619106 |
| — | ALPINE IMMUNE SCIENCES INC | 750,000 | $8.588M | 1.3% | $7.20 | — | COM | 02083G100 |
| GOSS | GOSSAMER BIO INC | 8,187,883 | $6.819M | 1.0% | $3.20 | -63.9% | COM | 38341P102 |
| — | AEROVATE THERAPEUTICS INC | 497,370 | $6.749M | 1.0% | $29.30 | — | COM | 008064107 |
| DNTH | DIANTHUS THERAPEUTICS INC | 480,000 | $6.562M | 1.0% | $12.62 | 0.0% | COM | 252828108 |
| DYN | DYNE THERAPEUTICS INC | 692,945 | $6.209M | 1.0% | $12.99 | -17.1% | COM | 26818M108 |
| PMVP | PMV PHARMACEUTICALS INC | 904,000 | $5.551M | 0.9% | $6.03 | +14.1% | COM | 69353Y103 |
| — | INOZYME PHARMA INC | 1,300,000 | $5.46M | 0.8% | $4.25 | — | COM | 45790W108 |
| XLO | XILIO THERAPEUTICS INC | 2,318,500 | $4.892M | 0.8% | $2.77 | -3.9% | COM | 98422T100 |
| ANNX | ANNEXON INC | 2,050,000 | $4.838M | 0.7% | $4.77 | -36.6% | COM | 03589W102 |
| — | GLYCOMIMETICS INC | 3,000,000 | $4.5M | 0.7% | $1.26 | — | COM | 38000Q102 |
| VKTX | VIKING THERAPEUTICS INC | 375,000 | $4.151M | 0.6% | $4.46 | +220.4% | COM | 92686J106 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 812,895 | $3.894M | 0.6% | $6.44 | -0.0% | COM | 61225M102 |
| — | JASPER THERAPEUTICS INC | 4,468,114 | $3.128M | 0.5% | $1.81 | — | COM | 471871103 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 475,600 | $3.077M | 0.5% | $4.28 | — | SPONSORED ADS | 152309100 |
| VIR | VIR BIOTECHNOLOGY INC | 325,050 | $3.046M | 0.5% | $25.11 | -43.2% | COM | 92764N102 |
| TVTX | TRAVERE THERAPEUTICS INC | 300,000 | $2.682M | 0.4% | $21.26 | -33.6% | Call | 89422G107 |
| LXRX | LEXICON PHARMACEUTICALS INC | 1,923,076 | $2.096M | 0.3% | $2.65 | -33.9% | COM NEW | 528872302 |
| ORIC | ORIC PHARMACEUTICALS INC | 204,500 | $1.237M | 0.2% | $5.68 | +44.3% | COM | 68622P109 |
| — | ITEOS THERAPEUTICS INC | 102,000 | $1.117M | 0.2% | $18.03 | — | COM | 46565G104 |
| — | CYMABAY THERAPEUTICS INC | 60,000 | $895K | 0.1% | $7.72 | — | Put | 23257D103 |
| — | BIONOMICS LIMITED | 168,000 | $454K | 0.1% | $2.70 | — | ADS | 09063M205 |
| — | HEPION PHARMACEUTICALS INC | 67,500 | $337K | 0.1% | $10.50 | — | COM NEW | 426897302 |